We tread where the fearful will not...We are the TIP of the SPEAR...We are BIOTECHNOLOGY INVESTORS

from HARRIS

Quote:

---

That Four-Letter Word: Risk 

So what's not to love? In a word: RISK. The market's graveyard is littered with developmental biotechnology companies that had a great idea and successful trials, but in the end, no FDA approvable drugs. In fact, there is no contest between small cap biotechnology stocks that made it and those that didn't. As much as I love this sector, it is built upon a foundation of quicksand. What makes Cellceutix different from all of those companies that fell into obscurity? That is the question that values this company at a paltry $150M. My bet is that in the years ahead, Cellceutix will be a billion dollar company. But in the end, it is only an bet, informed as it may be.